Sign in
Taking peopleNo phase

Looking for spondyloarthritis in adults with sudden inflammation at the front of the eye

Studies how often spondyloarthritis occurs in adults with acute anterior uveitis.

Key facts

Who runs it
Marmara University
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Observational Prospective Turkish Inception Cohort of Uveitis and Spondyloarthritis
Status
Recruiting
People taking part
100 people, planned
Started
15 Jan 2023
Expected to end
15 Jan 2030
Type of study
Observational
Record updated
6 December 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with uveitis, an inflammation inside the eye, seen at eye clinics. It studies how often they also have spondyloarthritis, an inflammatory joint and back disease.

Age
18 Years to 75 Years
Sex
All
Disease stage
Uveitis. The study focuses on acute anterior uveitis, a sudden inflammation at the front of the eye.
Biomarker or test result
Both HLA-B27-positive and HLA-B27-negative people are studied.

Main reasons for not taking part

  • Spondyloarthritis diagnosed before the uveitis attack
  • Uveitis caused by an infection

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • patients with uveitis

Who cannot take part

  • patients diagnosed spondyloarthiritis before from the uveitis attack
  • patients with infectious uveitis

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

This trial is currently available in Türkiye.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Spondyloarthritis (SpA) encompasses a group of inflammatory rheumatic diseases characterized by axial and/or peripheral arthritis, along with extra-articular manifestations such as enthesitis, dactylitis, uveitis, and skin lesions. Axial spondyloarthritis (axSpA), the hallmark of which is chronic sacroiliitis, can progress to vertebral fusion ("bamboo spine") in advanced cases. The prevalence of axSpA varies globally, ranging from 0.1% to 1.4%, with a higher incidence in men and a typical onset in the second or third decades of life. Diagnostic approaches include imaging techniques such as sacroiliac MRI and radiographs, alongside clinical criteria like inflammatory back pain, NSAID responsiveness, peripheral arthritis, and HLA-B27 positivity. Disease management primarily involves NSAIDs, with biologics used for refractory cases, and disease activity is monitored using indices such as BASDAI and ASDAS.

Read full original descriptionShow less

Acute anterior uveitis (AAU) is the most common extra-articular manifestation of SpA, particularly associated with HLA-B27 positivity. It often presents unilaterally with redness, pain, and photophobia but can lead to severe complications if inadequately treated. Around 50% of patients with HLA-B27-positive AAU have underlying SpA, and the prevalence of uveitis increases with longer disease duration. While the link between SpA and AAU is well-established, further research is needed to determine optimal systemic treatment and follow-up protocols. This study aims to assess the prevalence and clinical characteristics of SpA in patients presenting with AAU at ophthalmology clinics.

The group in the trial

  • main cohort

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Assessment of Spondyloarthritis in an Acute Anterior Uveitis Inception Cohort: a Cross Sectional and Prospective Comparative Study of HLA-B27-positive and -negative Cases
Plain-language title
Looking for spondyloarthritis in adults with sudden inflammation at the front of the eyeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT06720376, who can take part
Record updated
6 December 2024